Parvus Therapeutics Inc
Senior Scientist, Translational Immunology at Parvus Therapeutics Inc. to drive preclinical biomarker translation and validation.
Headquarters
South San Francisco, California, United States
Company Size
11-50 employees
Navicims — a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Parvus Therapeutics Inc.
5% below the average for this role
Lab Head, Quantitative, Translational and ADME Science
AbbVie
Director, Translational Biology
Vir Biotechnology
Manager, Clinical Biomarker Assays, Translational Science - Neuroscience
Arvinas
Associate Director, Bioanalytical Sciences & Biomarkers
Arbor Biotechnologies
Translational Specialist
Novo Nordisk A/S
Translational Scientist
ImmunEdge, Inc